The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Acetaminophen for osteoarthritis
Open accessAbstract
BACKGROUND: Osteoarthritis (OA) is the most common form of arthritis. Published guidelines and expert opinion are divided over the relative role of acetaminophen (also called paracetamol or Tylenol) and non-steroidal anti-inflammatory drugs (NSAIDs) as first-line pharmacologic therapy. The comparative safety of acetaminophen and NSAIDs is also important to consider. This update to the original 2003 review includes nine additional RCTs. OBJECTIVES: To assess the efficacy and safety of acetaminophen versus placebo and versus NSAIDs (ibuprofen, diclofenac, arthrotec, celecoxib, naproxen, rofecoxib) for treating OA. SEARCH STRATEGY: We searched MEDLINE (up to July 2005), EMBASE (2002-July 2005), Cochrane Central Register of Controlled Trials (CENTRAL), ACP Journal Club, DARE, Cochrane Database of Systematic Reviews (all from 1994 to July 2005). Reference lists of identified RCTs and pertinent review articles were also hand searched. SELECTION CRITERIA: Published randomized controlled trials (RCTs) evaluating the efficacy and safety of acetaminophen alone in OA were considered for inclusion. DATA COLLECTION AND ANALYSIS: Pain, physical function and global assessment outcomes were reported. Results for continuous outcome measures were expressed as standardized mean differences (SMD). Dichotomous outcome measures were pooled using relative risk (RR) and the number needed to treat (NNT) was calculated. MAIN RESULTS: Fifteen RCTs involving 5986 participants were included in this review. Seven RCTs compared acetaminophen to placebo and ten RCTs compared acetaminophen to NSAIDs. In the placebo-controlled RCTs, acetaminophen was superior to placebo in five of the seven RCTs and had a similar safety profile. Compared to placebo, a pooled analysis of five trials of overall pain using multiple methods demonstrated a statistically significant reduction in pain (SMD -0.13, 95% CI -0.22 to -0.04), which is of questionable clinical significance. The relative percent improvement from baseline was 5% with an absolute change of 4 points on a 0 to 100 scale. The NNT to achieve an improvement in pain ranged from 4 to 16. In the comparator-controlled RCTs, acetaminophen was less effective overall than NSAIDs in terms of pain reduction, global assessments and in terms of improvements in functional status. No significant difference was found overall between the safety of acetaminophen and NSAIDs, although patients taking traditional NSAIDS were more likely to experience an adverse GI event (RR 1.47, (95% CI 1.08 to 2.00). 19% of patients in the traditional NSAID group versus 13% in the acetaminophen group experienced an adverse GI event. However, the median trial duration was only 6 weeks and it is difficult to assess adverse outcomes in a relatively short time period. AUTHORS' CONCLUSIONS: The evidence to date suggests that NSAIDs are superior to acetaminophen for improving knee and hip pain in people with OA. The size of the treatment effect was modest, and the median trial duration was only six weeks, therefore, additional considerations need to be factored in when making the decision between using acetaminophen or NSAIDs. In OA subjects with moderate-to-severe levels of pain, NSAIDs appear to be more effective than acetaminophen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip
Towheed, T., Mc, H., Shea, B., & Wells, G. A. (1997) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000517 · Cited by 42
Self-citationRetractedStatistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
Self-citationSchulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
(2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1905::aid-anr1>3.0.co;2-p · Cited by 1,875
Cited by
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Self-citationChou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
OARSI recommendations for the management of hip and knee osteoarthritis
Zhang, W., Nuki, G., Moskowitz, R. W., Abramson, S., Altman, R. D., Arden, N. K., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.01.013 · Cited by 1,700
Self-citationZhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Abramoff, B., & Caldera, F. E. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.10.007 · Cited by 1,191
Pharmacological Management of Persistent Pain in Older Persons
American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02376.x · Cited by 1,008
Pharmacological Management of Persistent Pain in Older Persons
(2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00699.x · Cited by 916
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.06.014 · Cited by 796
Self-citationZhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., Gunther, K.-P., Hauselmann, H. J., Herrero-Beaumont, G., Jordan, K., Kaklamanis, P., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.028886 · Cited by 785
Bruyère, O., Honvo, G., Veronese, N., Arden, N. K., Branco, J., Curtis, E. M., Al-Daghri, N. M., Herrero-Beaumont, G., Martel-Pelletier, J., Pelletier, J.-P., et al. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.04.008 · Cited by 695
Ibuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 667
Christensen, R., Bartels, E. M., Astrup, A., & Bliddal, H. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065904 · Cited by 632
Chou, R., & Huffman, L. H. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00008 · Cited by 583
An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs
Ong, C. K. S., Lirk, P., Tan, C. H., & Seymour, R. A. (2007) · Clinical Medicine & Research · doi:10.3121/cmr.2007.698 · Cited by 587
Machado, G. C., Maher, C. G., Ferreira, P. H., Pinheiro, M. B., Lin, C.-W. C., Day, R. O., McLachlan, A. J., & Ferreira, M. L. (2015) · BMJ · doi:10.1136/bmj.h1225 · Cited by 580
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
Nuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W. S., Tschannen, B., Altman, D. G., Egger, M., & Juni, P. (2010) · BMJ · doi:10.1136/bmj.c3515 · Cited by 559
Current research on pharmacologic and regenerative therapies for osteoarthritis
Zhang, W., Ouyang, H., Dass, C. R., & Xu, J. (2016) · Bone Research · doi:10.1038/boneres.2015.40 · Cited by 495
Osteoarthritis: Diagnosis and Treatment
(1961) · BMJ · doi:10.1136/bmj.1.5222.355-a · Cited by 452
Deyle, G. D., Allison, S. C., Matekel, R. L., Ryder, M. G., Stang, J. M., Gohdes, D. D., Hutton, J. P., Henderson, N. E., & Garber, M. B. (2005) · Physical Therapy · doi:10.1093/ptj/85.12.1301 · Cited by 448
Management of chronic pain in older adults
Reid, M. C., Eccleston, C., & Pillemer, K. (2015) · BMJ · doi:10.1136/bmj.h532 · Cited by 405
Bannuru, R. R., Natov, N. S., Dasi, U. R., Schmid, C. H., & McAlindon, T. E. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.09.014 · Cited by 388
Babatunde, O. O., Jordan, J. L., Van der Windt, D. A., Hill, J. C., Foster, N. E., & Protheroe, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178621 · Cited by 383
Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome
Moore, R. A., Straube, S., & Aldington, D. (2013) · Anaesthesia · doi:10.1111/anae.12148 · Cited by 362
Management of Persistent Pain in the Older Patient: A Clinical Review
Makris, U. E., Abrams, R. C., Gurland, B., & Reid, M. C. (2014) · JAMA · doi:10.1001/jama.2014.9405 · Cited by 316
Braces and orthoses for treating osteoarthritis of the knee
Duivenvoorden, T., Brouwer, R. W., van Raaij, T. M., Verhagen, A. P., Verhaar, J. A., & Bierma-Zeinstra, S. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004020.pub3 · Cited by 314
Curcuminoid Treatment for Knee Osteoarthritis: A Randomized Double‐Blind Placebo‐Controlled Trial
Panahi, Y., Rahimnia, A., Sharafi, M., Alishiri, G., Saburi, A., & Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5174 · Cited by 310
Long‐term adverse effects of paracetamol – a review
McCrae, J. C., Morrison, E. E., MacIntyre, I. M., Dear, J. W., & Webb, D. J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13656 · Cited by 308
Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews
Kroenke, K., Krebs, E. E., & Bair, M. J. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.12.006 · Cited by 307
Acupuncture for peripheral joint osteoarthritis
Manheimer, E., Cheng, K., Linde, K., Lao, L., Yoo, J., Wieland, S., van der Windt, D. A., Berman, B. M., & Bouter, L. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001977.pub2 · Cited by 302
Herrero‐Beaumont, G., Ivorra, J. A. R., del Carmen Trabado, M., Blanco, F. J., Benito, P., Martín‐Mola, E., Paulino, J., Marenco, J. L., Porto, A., Laffon, A., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22371 · Cited by 287
Gait modification strategies for altering medial knee joint load: A systematic review
Simic, M., Hinman, R. S., Wrigley, T. V., Bennell, K. L., & Hunt, M. A. (2011) · Arthritis Care & Research · doi:10.1002/acr.20380 · Cited by 278
A Mind-Body Program for Older Adults With Chronic Low Back Pain: A Randomized Clinical Trial
Morone, N. E., Greco, C. M., Moore, C. G., Rollman, B. L., Lane, B., Morrow, L. A., Glynn, N. W., & Weiner, D. K. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8033 · Cited by 258
A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States
Blieden, M., Paramore, L. C., Shah, D., & Ben-Joseph, R. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.904744 · Cited by 261
Chondroitin for osteoarthritis
Singh, J. A., Noorbaloochi, S., MacDonald, R., & Maxwell, L. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005614.pub2 · Cited by 260
Self-citationType 2 diabetes mellitus and osteoarthritis
Veronese, N., Cooper, C., Reginster, J.-Y., Hochberg, M., Branco, J., Bruyère, O., Chapurlat, R., Al-Daghri, N., Dennison, E., Herrero-Beaumont, G., et al. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.01.005 · Cited by 258
Self-citationNuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W. S., Burgi, E., Scherer, M., Altman, D. G., & Juni, P. (2009) · BMJ · doi:10.1136/bmj.b3244 · Cited by 248
Data Extraction Errors in Meta-analyses That Use Standardized Mean Differences
Gøtzsche, P. C., Hróbjartsson, A., Marić, K., & Tendal, B. (2007) · JAMA · doi:10.1001/jama.298.4.430 · Cited by 238
Acetaminophen/paracetamol: A history of errors, failures and false decisions
Brune, K., Renner, B., & Tiegs, G. (2015) · European Journal of Pain · doi:10.1002/ejp.621 · Cited by 213
“Most patients, however, prefer a modern NSAID (Towheed et al., 2006).”
BackgroundInfluentialParacetamol: A Review of Guideline Recommendations
Freo, U., Ruocco, C., Valerio, A., Scagnol, I., & Nisoli, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153420 · Cited by 208
“In a Cochrane review of 15 RCTs involving 5986 participants, paracetamol was superior to placebo in five out of seven RCTs with a 5% relative improvement from baseline and a number-needed-to-treat of four to 16 to achieve a pain improvement; treatment with paracetamol did not modify WOMAC outcome [86].”
BackgroundSingle dose oral analgesics for acute postoperative pain in adults
Moore, R. A., Derry, S., McQuay, H. J., & Wiffen, P. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008659.pub2 · Cited by 198
Paracetamol versus placebo for knee and hip osteoarthritis
Leopoldino, A. O., Machado, G. C., Ferreira, P. H., Pinheiro, M. B., Day, R., McLachlan, A. J., Hunter, D. J., & Ferreira, M. L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013273 · Cited by 167
“Paracetamol is a widely used analgesic for hip or knee osteoarthritis but the evidence on its benefits and harms remains controversial (Towheed 2006; Zhang 2004; Zhang 2010).”
BackgroundRahme, E., Barkun, A., Nedjar, H., Gaugris, S., & Watson, D. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01811.x · Cited by 138
“The evidence to date suggests that tNSAIDs are superior to acetaminophen and may be preferred by patients for controlling moderate-to-severe OA pain (7, 10, 11).”
BackgroundAcetaminophen for Chronic Pain: A Systematic Review on Efficacy
Ennis, Z. N., Dideriksen, D., Vægter, H. B., Handberg, G., & Pottegård, A. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12527 · Cited by 129
Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?
Conaghan, P. G., Arden, N., Avouac, B., Migliore, A., & Rizzoli, R. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00658-9 · Cited by 101
Katz, J. N., Smith, S. R., Collins, J. E., Solomon, D. H., Jordan, J. M., Hunter, D. J., Suter, L. G., Yelin, E., Paltiel, A. D., & Losina, E. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.10.006 · Cited by 83
Qi, D. S., May, L. G., Zimmerman, B., Peng, P., Atillasoy, E., Brown, J. D., & Cooper, S. A. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.11.003 · Cited by 26
Choice of Comparator in Active Control Trials of New Drugs
Luijn, J. C. V., Loenen, A. C. V., Gribnau, F. W., & Leufkens, H. G. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l115 · Cited by 21
Metadata
- Authors
- Towheed, T., Maxwell, L., Judd, M., Catton, M., Hochberg, M. C., & Wells, G. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2006-01-25
- Volume
- 2010
- Issue
- 1
- Pages
- CD004257-CD004257
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2118200369
- Cited by
- 563
- References
- 66
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.